MICA · CARE LEARNING NOTES
Observe, keep care safe and communicate
An intramuscular injection requires an authorised route for the product, competent landmark identification and assessment of the patient. An illustration does not replace supervised practical training.
Confirm route and indication
Identify the patient and check the prescription and actual presentation available. The intramuscular route cannot replace another route merely because it seems easier. Review known allergies, previous reactions and information in the record that may change site selection or monitoring. A doubtful prescription or missing information requires clarification before administration by the authorised professional.
[1][2][3]Adapt equipment and site
The choice of site and equipment depends on anatomy, product and clinical context. For vaccines, CDC guidance relates this choice to factors including body build and the recommended route. This vaccine guidance is not a universal rule for every injectable. If landmarks cannot be identified confidently, request supervision instead of choosing an approximate area or applying a single routine.
[2]Prepare safely
Maintain clean preparation and equipment asepsis. A used needle or syringe must never re-enter a vial. Labelling on a prepared syringe must allow reliable identification; an unidentified product must not be administered solely because someone says it is the expected treatment. The sharps container must be accessible, and immediate disposal after use avoids hazardous handling.
[1][2]Site, equipment and technique depend on the product and patient characteristics. Guidance intended for vaccination must not be extrapolated to every intramuscular medicine. Ask about previous reactions and bleeding risk; unusual severe pain or a deficit after injection requires assessment.
- Check the authorised route in the product information and prescription.
Assess tolerance after care
Monitor pain and the site according to the product and protocol. Unusual severe pain, a new sensory or motor deficit, rapidly increasing swelling or persistent bleeding requires prompt assessment. Associated respiratory or circulatory signs require emergency escalation. Record the medicine, time, site and incidents; for a vaccine, also record the traceability details required by the applicable programme.
[1][2][3]A learning situation
FICTIONAL SITUATION · REFLECTION WITHOUT A SCORE
Fictional situation: a student prepares a prescribed injection but cannot identify anatomical landmarks on the patient. She proposes copying the location seen on another patient.
What makes care safer?
Read the reasoning
Pause the procedure and ask the supervising professional to reassess site and equipment. Landmarks and body build are not interchangeable between people. Recheck the product and authorised route before supervised care. Reporting difficulty protects the patient and enables appropriate learning; an approximate puncture must not be used to compensate.
References and scope
- Preventing Unsafe Injection Practices ↗
- Vaccine Administration: During Vaccination ↗
- Preventing and Managing Adverse Reactions ↗
Original documentary teaching summary for adult care. Procedures and medicines depend on professional competence, prescription and institutional procedures. International references do not establish an Algerian protocol. Independent human scientific review remains to be confirmed.